Analyst Ratings For NASDAQ:CPIX – Cumberland Pharmaceuticals (NASDAQ:CPIX)
Today, B. Riley initiated coverage on NASDAQ:CPIX – Cumberland Pharmaceuticals (NASDAQ:CPIX) with a Buy with a price target of $9.25.
Some recent analyst ratings include
- 4/17/2018-B. Riley initiated coverage with a Buy rating.
Recent Insider Trading Activity For NASDAQ:CPIX – Cumberland Pharmaceuticals (NASDAQ:CPIX)
NASDAQ:CPIX – Cumberland Pharmaceuticals (NASDAQ:CPIX) has insider ownership of 39.50% and institutional ownership of 34.70%.
- On 3/19/2018 Michael Bonner, CFO, bought 300 with an average share price of $6.72 per share and the total transaction amounting to $2,016.00.
- On 11/22/2017 Michael Bonner, CFO, bought 250 with an average share price of $7.81 per share and the total transaction amounting to $1,952.50.
- On 11/20/2017 Kenneth Krogulski, Director, bought 3,300 with an average share price of $7.55 per share and the total transaction amounting to $24,915.00.
- On 8/23/2017 Michael Bonner, CFO, bought 500 with an average share price of $6.72 per share and the total transaction amounting to $3,360.00.
- On 5/31/2017 Michael Bonner, CFO, bought 300 with an average share price of $6.95 per share and the total transaction amounting to $2,085.00.
- On 4/7/2017 Thomas R. Lawrence, Director, sold 6,000 with an average share price of $6.40 per share and the total transaction amounting to $38,400.00.
- On 3/23/2017 Michael Bonner, CFO, bought 900 with an average share price of $6.42 per share and the total transaction amounting to $5,778.00.
Recent Trading Activity for NASDAQ:CPIX – Cumberland Pharmaceuticals (NASDAQ:CPIX)
Shares of NASDAQ:CPIX – Cumberland Pharmaceuticals closed the previous trading session at 6.88 up +0.35 5.33% with 6.699999809265137 shares trading hands.